TMCnet News

Primary Myelofibrosis Forecast in 8 Major Markets 2016-2026 - Research and Markets
[April 19, 2016]

Primary Myelofibrosis Forecast in 8 Major Markets 2016-2026 - Research and Markets


Research and Markets has announced the addition of the "Primary Myelofibrosis Forecast in 8 Major Markets 2016-2026" report to their offering.

This report provides the current prevalent population for PMF across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight, several of the main symptoms and co-morbidities of PMF have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for PMF include:

  • Portal hypertension
  • Thrombosis
  • Anaemia
  • Gout
  • Extramedullary haematopoiesis
  • Leukocytosis
  • Splenomegaly
  • Acute myeloid leukaemia


Reason to buy:

  • Able to quantify patient populations in global PMF's market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of PMF and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on PMF's prevalent population.
  • Identify sub-populations within PMF which require treatment.
  • Gain an understanding of the specific markets that have the largest number of PMF patients.

Key Topics Covered:


1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis (News - Alert) & Clinical Course

7. Key Co-morbid Conditions/Features Associated with the Disease

8. Methodology for Quantification of Patient Numbers

9. Top-Line Prevalence for Primary Myelofibrosis

10. Features of PMF Patients

11. Abbreviations used in the Report

12. Patient-Based Offering

13. Online Pricing Data and Platforms

For more information visit http://www.researchandmarkets.com/research/8hf6s2/primary


[ Back To TMCnet.com's Homepage ]